Package Leaflet: Information for the User
Rivaroxaban Huahai 15mg film-coated tablets EFG
Rivaroxaban Huahai 20mg film-coated tablets EFG
Read the entire package leaflet carefully before you start taking this medicine, because it contains important information for you.
Contents of the package leaflet
This medicine contains the active substance rivaroxaban and is used in adults to:
Rivaroxaban Huahai is used in children and adolescents under 18 years of age and with a body weight of 30 kg or more to:
Rivaroxaban belongs to a group of medicines called antithrombotic agents. It works by blocking a factor involved in blood clotting (factor Xa) and thus reducing the tendency of blood to form clots.
Do not take Rivaroxaban
Do not take Rivaroxaban and inform your doctorif any of these conditions apply to you.
Warnings and precautions
Talk to your doctor or pharmacist before taking Rivaroxaban.
Be careful with Rivaroxaban
Tell your doctorif you have any of these conditionsbefore taking rivaroxaban. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If you need surgery:
Children and adolescents
Rivaroxaban Huahai tablets are not recommended in children with a body weight below 30kg.
There is not enough information about the use of rivaroxaban 15mg/20mg in children and adolescents for the indications in adults.
Other medicines and Rivaroxaban Huahai
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines, including those obtained without a prescription.
? any medicine for a fungal infection (e.g. fluconazole, itraconazole, voriconazole, posaconazole), unless it is only applied to the skin
? ketoconazole tablets (used to treat Cushing's syndrome, in which the body produces too much cortisol)
? any medicine for bacterial infections (e.g. clarithromycin, erythromycin)
? any antiviral medicine for HIV/AIDS (e.g. ritonavir)
? other medicines to reduce blood clotting (e.g. enoxaparin, clopidogrel or vitamin K antagonists, such as warfarin or acenocoumarol)
? anti-inflammatory medicines or pain relievers (e.g. naproxen or acetylsalicylic acid)
? dronedarone, a medicine for the treatment of irregular heartbeat
? some medicines for the treatment of depression (selective serotonin reuptake inhibitors (SSRIs) or serotonin and norepinephrine reuptake inhibitors (SNRIs))
If any of these conditions apply to you,tell your doctorbefore taking rivaroxaban, as the effect of rivaroxaban may be increased. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If your doctor thinks you are at increased risk of stomach or intestinal ulcers, they may recommend that you also take a medicine to prevent ulcers.
? any medicine for the treatment of epilepsy (phenytoin, carbamazepine, phenobarbital)
? St. John's Wort (Hypericum perforatum), a herbal medicine for the treatment of depression
? rifampicin, an antibiotic
If any of these conditions apply to you, tell your doctorbefore taking rivaroxaban, as the effect of rivaroxaban may be reduced. Your doctor will decide if you should be treated with rivaroxaban and if you should be kept under closer observation.
Pregnancy and breastfeeding
Do not take rivaroxaban if you are pregnant or breastfeeding. If there is a possibility that you may become pregnant, use a reliable contraceptive while taking rivaroxaban. If you become pregnant while taking this medicine, tell your doctor immediately, who will decide how you should be treated.
Driving and using machines
Rivaroxaban may cause dizziness (common side effect) or fainting (uncommon side effect) (see section 4, "Possible side effects"). You should not drive or use machines if you are affected by these symptoms.
Rivaroxaban Huahai contains lactose and sodium.
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow the instructions for administration of this medicine exactly as told by your doctor. If you are unsure, talk to your doctor or pharmacist again.
You must take rivaroxaban with food.
Swallow the tablets, preferably with water.
If you have difficulty swallowing the tablet whole, talk to your doctor about other ways to take rivaroxaban. The tablet can be crushed and mixed with water or apple puree, immediately before taking it. Then take food.
If necessary, your doctor may also give you the crushed tablet through a gastric tube.
The recommended dose is one rivaroxaban 20 mg tablet once a day.
If you have kidney problems, the dose may be reduced to one rivaroxaban 15 mg tablet once a day.
If you need to undergo a procedure to treat blocked blood vessels in your heart (called percutaneous coronary intervention - PCI with stent insertion), there is limited evidence to reduce the dose to one rivaroxaban 15 mg tablet once a day (or to one rivaroxaban 10 mg tablet once a day if your kidneys do not work properly) in addition to an antiplatelet medicine such as clopidogrel.
The recommended dose is one rivaroxaban 15 mg tablet twice a day for the first 3 weeks. For treatment after 3 weeks, the recommended dose is one rivaroxaban 20 mg tablet once a day.
After at least 6 months of treatment for blood clots, your doctor may decide to continue treatment with one rivaroxaban 10 mg tablet once a day or one rivaroxaban 20 mg tablet once a day.
If you have kidney problems and are taking one rivaroxaban 20 mg tablet once a day, your doctor may decide to reduce your treatment dose to one rivaroxaban 15 mg tablet once a day after 3 weeks if the risk of bleeding is higher than the risk of having another blood clot.
The dose of rivaroxaban depends on body weight and will be calculated by your doctor.
Take each dose of rivaroxaban with a drink (e.g. water or juice) during a meal. Take the tablets every day at about the same time. Consider setting an alarm to remind you.
For parents or caregivers: watch the child to make sure they take the entire dose.
Since the dose of rivaroxaban is based on body weight, it is important to attend scheduled visits with your doctor, as the dose may need to be adjusted as the weight changes.
Never adjust the dose of rivaroxaban on your own. Your doctor will adjust the dose if necessary.
Do not split the tablet to try to get a fraction of the tablet dose. If a smaller dose is required, please use the alternative rivaroxaban granule presentation for oral suspension.
In children and adolescents who cannot swallow whole tablets, please use rivaroxaban granules for oral suspension.
If the oral suspension is not available, you can crush the rivaroxaban tablet and mix it with water or apple puree immediately before taking it. Take some food after taking this mixture. If necessary, your doctor may also give you the crushed rivaroxaban tablet through a gastric tube.
If you spit up the dose or vomit
Call your doctor if you spit up the dose or vomit repeatedly after taking rivaroxaban.
When to take Rivaroxaban Huahai
Take the tablet every day, until your doctor tells you to stop.
Try to take a tablet at the same time every day, to help you remember.
Your doctor will decide how long you should keep taking the treatment.
To prevent the formation of blood clots in the brain (stroke) or in other blood vessels:
If you need to have a procedure to restore a normal heartbeat, called cardioversion, take rivaroxaban at the times your doctor has indicated.
If you forget to take Rivaroxaban Huahai
If you take more Rivaroxaban Huahai than you should
Call your doctor immediately if you have taken too many rivaroxaban tablets. Taking too much rivaroxaban increases the risk of bleeding.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you stop taking Rivaroxaban Huahai
Do not stop taking rivaroxaban without talking to your doctor first, because rivaroxaban prevents the development of a serious condition.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Like other similar medicines to reduce blood clot formation, rivaroxaban can cause bleeding, which can endanger the patient's life. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be evident.
Tell your doctor immediately if you or your child suffer from any of the following adverse effects:
Your doctor will decide to keep you under closer observation or modify your treatment.
The frequency of these adverse effects is very rare (up to 1 in 10,000 people).
The frequencies of severe allergic reactions are very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).
General list of possible adverse effects found in adults, children, and adolescents
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(cannot be estimated from the available data)
Adverse effects in children and adolescents
In general, the adverse effects observed in children and adolescents treated with rivaroxaban were similar to those observed in adults and their severity was mainly mild to moderate.
Adverse effects that were more frequently observed in children and adolescents:
Very frequent(may affect more than 1 in 10 people)
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Reporting of adverse effects
If you experience adverse effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging and on each blister or bottle, after "CAD" or "EXP". The expiration date is the last day of the month indicated.
Rivaroxaban Huahai 15 mg:
This medicine does not require special storage conditions.
Rivaroxaban Huahai 20 mg:
Blister: Do not store above 25°C
Bottle: This medicine does not require special storage conditions.
Crushed tablets
Crushed tablets are stable in water or apple sauce for up to 4 hours.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Rivaroxaban Huahai
Rivaroxaban Huahai 15 mg: each tablet contains 15 mg of rivaroxaban.
Rivaroxaban Huahai 20 mg: each tablet contains 20 mg of rivaroxaban.
-Rivaroxaban Huahai 15 mg: partially hydrolyzed poly(vinyl alcohol), titanium dioxide (E 171), macrogol, talc, red iron oxide (E 172).
-Rivaroxaban Huahai 20 mg: partially hydrolyzed poly(vinyl alcohol), red iron oxide (E 172), talc, macrogol, yellow iron oxide (E 172), titanium dioxide (E 171), lecithin, black iron oxide (E 172).
Appearance of the product and package contents
-Rivaroxaban Huahai 15 mg: film-coated tablets, pink, round, and biconvex, engraved with "056" on one side and "S" on the other side.
They are packaged
-Rivaroxaban Huahai 20 mg: film-coated tablets, dark red, triangular, engraved with "057" on one side and "S" on the other side.
They are packaged
Only some pack sizes may be marketed.
Marketing authorization holder
Huahai Pharma Europe GmbH
Werner-Eckert, Strasse 4
81829 Munich
Germany
Manufacturer
L-A-W Services GmbH
Leipziger Arzneimittelwerk
Elisabeth-Schumacher-Str. 54/56
04328 Leipzig
Germany
This medicine is authorized in the Member States of the European Economic Area under the following names:
Germany: Rivaroxaban Huahai 15 mg/20 mg Filmtabletten
Belgium: Rivaroxaban Huahai 15 mg/20 mg filmomhulde tabletten
Spain: Rivaroxabán Huahai 15 mg/20 mg comprimidos recubiertos con película EFG
France: Rivaroxaban Huahai 15 mg/20 mg comprimé pelliculé
Italy: Rivaroxaban Huahai 15 mg/20 mg compressa rivestite con film
Netherlands: Rivaroxaban Huahai 15 mg/20 mg filmomhulde tabletten
Date of the last revision of this leaflet:04/2025
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/